Contact Us

Use the form on the right to contact us.

You can edit the text in this area, and change where the contact form on the right submits to, by entering edit mode using the modes on the bottom right. 

1145 River Rd, Suite 16
Charlottesville, VA 22901




  1. Bommareddy et al., “MEK inhibition enhances oncolytic virus immunotherapy through increased tumor cell killing and T cell activation“, Sci. Transl. Med. 10 (471): eaau0417, 2018.

  2. Hebert CG, DiNardo N, Evans DN, Hart SJ, and Hachmann A, “Rapid Quantification of Vesicular Stomatitis Virus in Vero cells using Laser Force Cytology”, Vaccine, 36 (41), 2018. See the paper here.

  3. Hebert CG, Hart SJ, Leski, TA, Terray A, Lu, Q, "Label-Free Detection of Bacillus anthracis Spore Uptake in Macrophage Cells Using Analytical Optical Force Measurements", Anal. Chem., 2017, 89 (19): 10296-10302. See the paper here.

  4. Hebert CG, Hart SJ, Terray A. "Label free detection of pseudorabies virus infection in Vero cells using laser force analysis", Analyst. 2014;139(6):1472-81. See the paper here.

  5. Hebert CG, Terray A, Hart SJ. "Toward label-free optical fractionation of blood-optical force measurements of blood cells", Anal Chem. 2011;83(14):5666-72. See the paper here.

related work


  1. Kenakin, T “Label-free assays: back to the (better) future”, Drug Discovery Today, 06 August 2012.

  2. Xi B, Yu N, Wang X, Xu X, Abassi YA, “The application of cell-based label-free technology in drug discovery”, Biotechnol J. 2008 Apr;3(4):484-95.

  3. Gorges TM et al., BMC Cancer. 2012;12(178).

  4. Parkinson DR, et al., Journal of Translational Medicine. 2012;10(138).

  5. Man Y, Wang Q, Kemmner W., J Clinic Experiment Pathol. 2011;1(1).

Infectious disease

  1. Zaas AK, et al. Cell Host Microbe. 2009;6:207.

  2. Zaas AK, et al. Sci Transl Med. 2013;5:203ra126

  3. Hu X, et al. Proc Natl Acad Sci USA. 2013;110:12792

  4. Smith CL, et al. NatComms 2014; 5649.

  5. Faix, J. Crit Rev Clin Lab Sci, 2013; 50(1):23.

  6. Berting A, Farcet, MR, and Kreil, TR. “Virus susceptibility of Chinese hamster ovary (CHO) cells and detection of viral contaminations by adventitious agent testing”, Biotechnology and Bioengineering, 106(4), 598, 2010.

Phenotypic Drug Discovery (PDD) Induced Pluripotent Stem Cells (iPSCs)

  1. Xi B, Yu N, Wang X, Xu X, Abassi YA, "The application of cell-based label-free technology in drug discovery", Biotechnol J. 2008 Apr;3(4):484-95.

  2. Terry K., “Label-free assays: back to the (better) future”, Drug Discovery Today, 06 August 2012.

Induced Pluripotent Stem Cells (iPSCs)

  1. Takahashi, K; Yamanaka, S (2006). "Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors". Cell 126 (4): 663–76.

  2. Yu J, Vodyanik MA, et al. (2007). "Induced Pluripotent Stem Cell Lines Derived from Human Somatic Cells". Science 318 (5858): 1917–1920

  3. Takahashi K, et al. (2007). "Induction of Pluripotent Stem Cells from Adult Human Fibroblasts by Defined Factors". Cell 131 (5): 861–872.

  4. Lowry WE, Quan WL (2010) Roadblocks en route to the clinical application of induced pluripotent stem cells. J Cell Sci 123:643–651.

  5. Knoepfler PS (2009) Deconstructing stem cell tumorigenicity: A roadmap to safe regenerative medicine. Stem Cells 27:1050–1056


Visit TheCyte, LumaCyte’s blog for news, information, Article reviews, and tech notes related to single cell analysis.